Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-046484
Filing Date
2020-08-12
Accepted
2020-08-12 20:01:26
Documents
1
Period of Report
2020-08-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 20646
  Complete submission text file 0001209191-20-046484.txt   22132
Mailing Address 220 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 220 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 416-7700
Principia Biopharma Inc. (Issuer) CIK: 0001510487 (see all company filings)

IRS No.: 263487603 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PRINCIPIA BIOPHARMA INC. 400 EAST JAMIE COURT, SUITE 302 SOUTH SAN FRANCISCO CA 94080
Business Address
Goldstein David M (Reporting) CIK: 0001751719 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38653 | Film No.: 201096732